
浏览全部资源
扫码关注微信
纸质出版日期:2018
移动端阅览
刘永萍, 杨如意. 清燥救肺汤加减治疗青海高原地区慢性支气管炎急性加重的临床分析[J]. 中国实验方剂学杂志, 2018,24(19):207-212.
LIU Yong-ping, YANG Ru-yi. Clinical Analysis of Qingzao Jiufei Tang in Treating Acute Exacerbation of Chronic Bronchitis in Qinghai Plateau[J]. Chinese journal of experimental traditional medical formulae, 2018, 24(19): 207-212.
刘永萍, 杨如意. 清燥救肺汤加减治疗青海高原地区慢性支气管炎急性加重的临床分析[J]. 中国实验方剂学杂志, 2018,24(19):207-212. DOI: 10.13422/j.cnki.syfjx.20181938.
LIU Yong-ping, YANG Ru-yi. Clinical Analysis of Qingzao Jiufei Tang in Treating Acute Exacerbation of Chronic Bronchitis in Qinghai Plateau[J]. Chinese journal of experimental traditional medical formulae, 2018, 24(19): 207-212. DOI: 10.13422/j.cnki.syfjx.20181938.
目的:探讨清燥救肺汤加减治疗高原地区慢性支气管炎急性加重(风燥伤肺证)患者的临床疗效及对炎症因子的影响。方法:将140例患者,以就诊先后按随机数字表法分为对照组和观察组各70例。两组患者均参照指南给予抗感染,祛痰、止咳治疗为主;口服盐酸莫西沙星片,0.4 g/次,1次/d,连续服用7 d;盐酸氨溴索片,30 mg/次,2次/d,连续服用14 d。对照组口服杏苏止咳颗粒,12 g/次,2次/d,温开水冲服。观察组采用清燥救肺汤加减,1剂/d。两组疗程均为连续治疗14 d。进行治疗前后咳嗽症状积分、咳嗽视觉模拟评分(VAS)和风燥伤肺证评分;记录咳嗽、咯痰、鼻干咽燥和肺部湿啰音消失时间;治疗前后行肺功能检查,记录用力肺活量(FVC),第1秒用力呼气容积(FEV1),FEV1占预计值百分比(FEV1%);检测治疗前后肿瘤坏死因子-α(TNF-α),白细胞介素-8(IL-8),单核细胞趋化蛋白-1(MCP-1),内皮素(ET)和丙二醛(MDA)水平。结果:观察组疾病疗效总有效率为93.65%,高于对照组的81.67%(χ2=4.122,P<0.05);观察组中医临床疗效总有效率为93.65%,高于对照组的80%(χ2=5.061,P<0.05);观察组患者咳嗽症状积分(日间和夜间),咳嗽VAS评分和风燥伤肺证评分均低于对照组(P<0.01);两组患者FEV1,FEV1/FVC和FEV1%均较治疗前有所改善(P<0.05),观察组的改善更为显著(P<0.05);观察组咳嗽、咯痰、鼻干咽燥和肺部湿啰音消失时间均短于对照组(P<0.05,P<0.01);观察组血清MCP-1,IL-8,TNF-α,ET和MDA水平均低于对照组(P<0.01)。结论:在西医常规抗感染等治疗的基础上,采用清燥救肺汤加减治疗青海高原地区慢性支气管炎加重(风燥伤肺证)患者,能快速控制临床症状,缩短病程,改善肺功能,并具有抗炎、抗氧化应激功能,有较好的临床疗效。
Objective: To discuss the clinical efficacy of addition and subtraction therapy of Qingzao Jiufei Tang to acute exacerbation of chronic bronchitis (wind dryness and lung injury) in plateau area and investigate its influence to inflammatory factors. Method: One hundred and forty patients were randomly divided into control group (70 cases) and observation group (70 cases) by random number table. Both groups received anti-infection treatment
dispelling phlegm and relieving cough. Moxifloxacin hydrochloride tablets for 7 days
0.4 g/time
qd
ambroxol hydrochloride tablets for 14 days
30 mg/time
bid. Patients in control group got Xingsu Zhike granules
12 g/time
bid
taken after being infused in warm boiled water. Patients in observation group got addition and subtraction therapy of Qingzao Jiufei Tang
1 dose/day. The treatment course was 14 days in both groups. Before and after treatment
scores of cough
visual analogue scale (VAS) of cough and scores of wind dryness and lung injury were graded. The disappearance time of cough
phlegm
dry nose and pharynx
rhonchi of lung were recorded. Both before and after treatment
the pulmonary function was detected
and levels of forced vital capacity (FVC)
forced expiratory volume in one second (FEV1)
percentage of FEV1 to expected value (FEV1%)
tumor necrosis factor-α (TNF-α)
interleukin-8 (IL-8)
monocyte chemoattractant protein-1
endothelin (ET) and malondialdehyde (MDA) were detected. Result: The total effective rate for the disease in observation group was 93.65%
better than 81.67%in control group (χ2=4.122
P<0.05). The total clinical effective rate for traditional Chinese medicine(TCM) in observation group was 93.65%
better than 80%in control group (χ2=5.061
P<0.05). Scores of cough symptoms (day and night)
VAS scores of cough and scores of wind dryness and lung injury in observation group were all lower than those in control group (P<0.01). FEV1
FEV1/FVC and FEV1% were improved than those before treatment in both groups (P<0.05)
and the improvement was more obvious in observation group (P<0.05). The disappearance periods of cough
phlegm
dry nose and pharynx
rhonchi of lung in observation group were shorter than those in control group (P<0.05
P<0.01). And the serum levels of MCP-1
IL-8
TNF-α
ET and MDA were lower than those in control group (P<0.01). Conclusion: Based on the routine western medicine treatment for anti-infection
Qingzao Jiufei Tang can quickly control clinical symptoms
shorten course of disease
and ameliorate pulmonary function
with anti-inflammatory and anti-oxidative stress functions when it is used for chronic bronchitis (wind dryness and lung injury) at acute exacerbation in plateau area.
0
浏览量
7
下载量
2
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621